Charles River Laboratories International CRL
NYSE CRL
$304.28 +5.26 (+1.76%)
As of: Oct 14, 2026 · 1:26 PM EDT

Charles River Laboratories International (CRL) Short-term Investments (2010 - 2011)

Updated

Charles River Laboratories International (CRL) posted Short-term Investments of $6.19 million for Q3 2011, down 47.5% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Short-term Investments (2010 - 2011) Analysis & Trends

At the end of FY2010, Charles River Laboratories International's Short-term Investments came in at $9.83 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.54 Bn 35.24 Bn 1.44 Bn
2 Medpace Holdings 17.33 Bn 15.39 Bn 201.64 Mn
3 Charles River Laboratories International 14.56 Bn 13.76 Bn 363.37 Mn
4 Icon 13.22 Bn 10.33 Bn 479.29 Mn
5 Fortrea Holdings 2.05 Bn 1.42 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 728.68 Mn -33.41 Mn 18.44 Mn
7 Evotec SE 504.32 Mn -1.11 Bn -
8 Champions Oncology 67.26 Mn 42.35 Mn 7.70 Mn
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 24, 2011 6.19 Mn
Jun 25, 2011 11.78 Mn
Dec 25, 2010 9.83 Mn
API Access

Charles River Laboratories International Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=CRL&period=max&api_key=YOUR_API_KEY